LAMISIL ATANTIFUNGAL (Novartis Consumer Health, Inc.)
Welcome to the PulseAid listing for the LAMISIL AT drug offered from Novartis Consumer Health, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Novartis Consumer Health, Inc. |
NON-PROPRIETARY NAME: | TERBINAFINE |
SUBSTANCE NAME: | TERBINAFINE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | GEL |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2010-01-01 |
END MARKETING DATE: | 0000-00-00 |
LAMISIL AT ANTIFUNGAL HUMAN OTC DRUG Details:
Item Description | LAMISIL AT ANTIFUNGAL from Novartis Consumer Health, Inc. |
LABELER NAME: | Novartis Consumer Health, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/g) |
START MARKETING DATE: | 2010-01-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0067-6239_02859315-2972-4db0-b18a-b787385a6072 |
PRODUCT NDC: | 0067-6239 |
APPLICATION NUMBER: | NDA021958 |
Other TERBINAFINE Pharmaceutical Manufacturers / Labelers: